About: Cardiovascular Drug Reviews

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cardiovascular Drug Reviews Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

journal

Attributes	Values
rdf:type	Item
description	journal (en) журнал (uk) periodiek (nl) مجلة (ar)
OpenCitations bibliographic resource ID	wds:Q13455172-1A2D9F6A-2DFB-494C-982E-50EB3EC3AD66
Scilit journal ID	wds:Q13455172-626EA43B-ED8A-4C04-BC88-B4D7A98B2F2E
Crossref journal ID	wds:Q13455172-E7110B3F-FA78-41A0-BA27-7DF5CA1E7F9F
OpenCitations bibliographic resource ID	https://w3id.org/oc/corpus/br/155797
OpenCitations bibliographic resource ID	155797
Scilit journal ID	203536
Crossref journal ID	58368
rdfs:label	Cardiovascular Drug Reviews (en) Cardiovascular Drug Reviews (nl)
skos:prefLabel	Cardiovascular Drug Reviews (en) Cardiovascular Drug Reviews (nl)
name	Cardiovascular Drug Reviews (en) Cardiovascular Drug Reviews (nl)
title	wds:Q13455172-D9D25465-0839-4C16-8747-288AE46E1435
title	Cardiovascular Drug Reviews (en)
ERA Journal ID	wds:Q13455172-493115DC-9CD8-42F0-8C0F-0B28B8F28643
ERA Journal ID	14708
NLM Unique ID	wds:Q13455172-F2782037-1312-4C80-BC08-9F49542C45F9
ACNP journal ID	wds:Q13455172-5673013F-4B67-4761-8644-1D3149C9512A wds:Q13455172-C58623C6-7CCE-4302-9379-8216A73AF2C0
HAL journal ID	wds:Q13455172-4E7712EC-CCB0-4CCE-A082-14AE25792F33
NLM Unique ID	9006912
ACNP journal ID	971329 2617248
HAL journal ID	11523
end time	wds:Q13455172-06f16f36-4862-97d7-4021-64078c038fde
end time	2007-01-01 00:00:00Z (xsd:dateTime)
followed by	wds:Q13455172-31ff0677-416f-cb53-322d-758a67bfac3e
instance of	wds:Q13455172-B65C16D0-CFA0-4D5C-8482-CEF222EFAA00
followed by	Cardiovascular Therapeutics
instance of	periodical
start time	wds:Q13455172-98796e37-4f48-2f80-8e26-ac458208333e
start time	1988-01-01 00:00:00Z (xsd:dateTime)
Scopus source ID	wds:Q13455172-145BCAB9-3E2B-426A-8CB1-2C53E37DF5C2
ISSN	wds:Q13455172-3B67C009-B3DA-4465-9CFC-E0E69D7B306F wds:Q13455172-E3A79407-8E94-4120-AA03-C961081960CA
indexed in bibliographic review	wds:Q13455172-631A6433-5ABA-41B2-8598-A129E2D946B1
ISSN	urn:ISSN:0897-5957 urn:ISSN:1527-3466
Scopus source ID	20129
ISSN	0897-5957 1527-3466
indexed in bibliographic review	Scopus
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q13455172 https://nl.wikipedia.org/wiki/Cardiovascular_Drug_Reviews
is follows of	Cardiovascular Therapeutics
is follows of	wds:Q1871490-382009cf-4c50-e192-736d-c0a8f7dac9a6
is published in of	Update on fenofibrate Pharmacology of the ACAT inhibitor avasimibe (CI-1011). Cardiovascular protective effects of resveratrol Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits Prevention of cardiovascular complications of diabetes mellitus by aspirin Development of the thyroid hormone receptor beta-subtype agonist KB-141: a strategy for body weight reduction and lipid lowering with minimal cardiac side effects Pharmacological profile and therapeutic potential of BM-573, a combined thromboxane receptor antagonist and synthase inhibitor Guinea pigs as models to study the hypocholesterolemic effects of drugs Bucillamine: a potent thiol donor with multiple clinical applications. Role of adenosine as adjunctive therapy in acute myocardial infarction Cardiovascular actions of berberine RWJ-58259: a selective antagonist of protease activated receptor-1. DY-9760e, a novel calmodulin inhibitor, exhibits cardioprotective effects in the ischemic heart Disodium disuccinate astaxanthin (Cardax): antioxidant and antiinflammatory cardioprotection Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396. Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor The many faces of H89: a review Rosuvastatin: a highly effective new HMG-CoA reductase inhibitor. The functional consequence of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in young healthy volunteers. The low molecular weight heparin, tinzaparin, in thrombosis and beyond. Ibudilast: a non-selective PDE inhibitor with multiple actions on blood cells and the vascular wall. Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular diseases Zoniporide: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1). C-reactive protein (CRP)-lowering agents Lipoprotein lipase activator NO-1886. Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trials Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control DX-9065a, a direct inhibitor of factor Xa. Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors. Bivalirudin: pharmacology and clinical applications Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors Oxidative stress as the leading cause of acute myocardial infarction in diabetics Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease Cardiovascular properties of yangambin, a lignan isolated from Brazilian plants An overview of SR121463, a selective non-peptide vasopressin V(2) receptor antagonist Potential use of beta(3)-adrenoceptor antagonists in heart failure therapy Role of tissue factor pathway inhibitor in the regulation of tissue factor-dependent blood coagulation Cardiovascular effects of androgens N-(p-amylcinnamoyl)anthranilic acid (ACA): a phospholipase A(2) inhibitor and TRP channel blocker The novel antiarrhythmic drug dronedarone: comparison with amiodarone Statins, nitric oxide and neovascularization Perhexiline Ifetroban sodium: an effective TxA2/PGH2 receptor antagonist. Therapeutic potential of VIVIT, a selective peptide inhibitor of nuclear factor of activated T cells, in cardiovascular disorders Multilateral in vivo and in vitro protective effects of the novel heat shock protein coinducer, bimoclomol: results of preclinical studies. Therapeutic use of citrulline in cardiovascular disease

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software